$PDXP Very good read from a PDXP Shareholder:  From -

New Post Public Reply Private Reply Replies (0) Message Board
jonny_red32
210
$PDXP Very good read from a PDXP Shareholder: 

From - @analyze4dollars 

Pdx Partners, Inc. ( (PDXP)0.0045 ◊ 0.0 (0.00%)Volume: 0 @- ET 

BidAskDay's Range0.0040.0052- - -PDXP Detailed Quote1D1M2M3M6M1Y2Y3Y5Y 

Sure Trader - Start Trading Stocks & Options with only $500 

PDX Partners, Inc. Further Enhances Net Stock Holder Equity InvestorsHub NewsWire - 10/30/2017 9:10:22 AM 

SOG  Sunday, 02/25/18 12:16:15 PMRe: Porteño post# 342570Post #  of 34415  

$PDXP is scheduled to resume trading on the Grey Market on 5 March. As such, many questions have been asked of me about the differences in a grey market vs a pink market.  

A Grey Market consists of no market makers, no bid, no ask, no manipulation and exact matched orders for both share lot and price. Extremely volatile and erratic trading is commonplace and only time & sales is available to show you the last transactions. All orders will be executed with limit orders, which means no market orders are available. The largest volume is likely within the first 1-3 days then volume commonly dies.  

You can expect very volatile trading with extreme fluctuation in prices both low & high with the overall theme for the first day being red. However, the exact same share structure conditions are present now that were present pre-suspension which gave us our low volume prior to the suspension. Since we had low volume and near float lock like conditions with extensive manipulation in the days immediately before the suspension, all shorts will be required to cover & now it will be much harder for them to do so on greys. A common misconception is that covers will force the price up in all cases. This is not the case if shares become immediately available through retail selling, then covers happen at a discount and shorts win big. THIS IS THEIR GOAL…Everyone is blind meaning manipulative practices will grind to a halt. These are some of the positives associated with the grey market.  

In some unique cases, stocks heavily manipulated thrive on the grey market due to the lack of manipulation. BIT*CF is an example of a stock that was relegated to the grey market in August 2017. The first day on resumption of trading it opened at .40 cents, low of day was .0018, high of day was .95 and it closed at .58. The close before suspension was $1.79. From 8 September to 18 December, it proceeded to run from the low of .0018 to $2.05.  

A sharp drop is expected but staying in trips for long isn’t likely if at all since about 250-300 mil are held by people that aren’t going to sell the large majority of their shares and those same people will be adding large on any hard dips. By buying on any hard dips you directly compete against any retail or MM’s short in a grey market. They are powerless now and can only see the same things we see as retail. Any buys on the part of retail (YOU) directly decreases their ability to cover at a low price and decreases likelihood of a big win for them. Not to mention decreasing your average price, reducing your loss and giving you the potential to turn a loss into a win. Remember the drops will be temporary and the fluctuations extreme so in order to scoop up those deep discounts you have to set your bids as soon as the market opens otherwise you will likely miss out on the opportunity to manage the trade effectively.  

Question: How long will $PDXP stay on the grey market?  
Answer: Forever until a broker submits a form 211 on behalf of PDXP. https://www.otcmarkets.com/learn/getting-traded  
Not a likely scenario unless the SEC comes out with a statement completely vindicating PDXP of any wrong doing OR they release a statement noting they will not pursue any action against the company. The occurrence of that is the only way a broker would submit a 211. I’ve never been involved in the process of the submitting a 211 but I understand that it involves several round table discussions and back and forth responses are required which commonly takes between 6-8 months and more.  

One thing in PDXP’s favour is that Patrick is very aggressive and will strive to get it done as quickly as possible. In addition, Patrick has followed through with EVERYTHING he has stated would happen. I don’t doubt he will aggressively pursue this in multiple ways. IMO a lawsuit against the SEC and other entities involved in the smear campaign is warranted. As I understand, he is already working on filing the 211 with the help of a ton of people and from the sounds of it NVC is going to fully support them in any way they can although that wasn’t their original intent. You can absolutely expect an update from Patrick and we’ve already seen updates from NVC since the suspension so I’m sure you can expect more from them in the near future. The best step for them would be to release the updates the day it resumes trading.  

Any update of the above mentioned events or a PR could completely change the game relative to positive price change or stabilization of the price but it won’t change the occurrence of the grey market, the float lock conditions or the fact myself and others will be buying large on the drops.
Engineer by trade & Swing Trader at Heart!

Join Webull today and get up to 75 #FREE stocks!
Get started >> Register with my referral link now>> JOIN HERE NOW


CLICK TO SEE --> Engineer, Design,& Build Packaging Equipment






Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hansa's Idefirix Shows Promise for Kidney Transplants

Updated Category News Views 11

Compelling Progress from Hansa Biopharma Y'know, navigating through the biotech jungle isn't for the faint-hearted. Hansa Biopharma's recent results with Idefirix could just be the beacon of hope for patients struggling on transplant lists. Announced at the ASN Kidney Week—a name that's got weight, by the way—these findings aren't just filling space. They're promising...

Continue Reading
Concierge Hybrid Choice™: Transforming Patient Care

Updated Category News Views 22

A New Way to Nurture Patient Relationships This isn't just another cookie-cutter patient care program rolling out—it’s a genuine shake-up in the way doctors connect with their patients. Rishika Kaundal, MD, a dedicated family medicine physician, is pioneering change in Midlothian, Virginia with her Hybrid Choice™ concierge program. This isn't a fluff piece; it's a...

Continue Reading
Dimethylaminopropylamine Market Eyes $732M by 2035

Updated Category News Views 21

Surfactants and Epoxy Fuel Dimethylaminopropylamine Demand Hot off the presses, folks! Dimethylaminopropylamine, or DMAPA if you're into acronyms, is gearing up for a steady climb to a $731.9 million market value by the year 2035. That's quite the leap from the $452.6 million we saw back in 2025. According to Credence Research's latest estimates, this amine is hitching...

Continue Reading
BOB Raises $5.5M for AI Banking Platform Revolution

Updated Category News Views 24

Cracking the Code of Small Business Finance BOB, a Miami hotshot aiming to be more than just another fintech flash in the pan, has wrangled a sweet $5.5 million in seed capital. They're shaking hands with big names like Peter Thiel and the mastermind behind Plaid, Zak Perret, through Mischief Ventures. The plan? To build an AI-powered finance savior for small businesses...

Continue Reading
First Citizens Surprises with Q3 Gains and Buyback Plan

Updated Category News Views 5

Unexpected Third Quarter Tailwinds for First Citizens There are days in this trading gig when a bank I'll barely sneeze at hits out of the park. First Citizens BancShares (NASDAQ:FCNCA) pulled off such a feat, wringing out a third-quarter 2026 performance that beat their own benchmarks. They threw $600 million back to shareholders in repurchased stocks while repaying an...

Continue Reading
Blockchain Boom: Media Market to Hit $3.33B by 2035

Updated Category News Views 35

Blockchain is Not Just for Bitcoin Anymore Who would've thought, right? Blockchain's no longer just the playground for cryptocurrency enthusiasts. Today, it's making waves in the media and entertainment sector. Latest numbers from Credence Research have this market set to explode from $748 million in 2025 to a jaw-dropping $3.33 billion by 2035. Yeah, folks, that's a...

Continue Reading
Concrete Admixtures Market: A Billion-Dollar Boom

Updated Category News Views 24

A Look Under the Hood of Concrete Admixtures It's a concrete jungle out there, folks—literally. The once overlooked market of concrete admixtures is gearing up for quite the makeover, projected to hit USD 35.87 billion by 2035. For those of you tuning in, we're talking about chemicals that mix into your average concrete to change its properties. And, believe it or not,...

Continue Reading
Estrogen Patch Struggles: Menopause Care Needs a Boost

Updated Category News Views 25

Troublesome Estrogen Patch Shortages Hit Hard You'd think getting a prescription filled would be a simple task, right? Well, think again. Midi Health shines a glaring light on how the supposed ease of getting hormone therapy is anything but for many women in 2026. Out of those scrambling for estradiol patches, 44% hit roadblocks in pharmacies, and a third hit an all-out...

Continue Reading
CardVault by Tom Brady Expands to Pittsburgh

Updated Category News Views 4

Tom Brady’s CardVault Hits Pittsburgh’s Historic Strip District Pittsburgh just got another feather in its cap with CardVault by Tom Brady marking its 20th store at The Terminal. As if this city needed more sports excitement! Pittsburgh, with its die-hard Steelers, Penguins, and Pirates fans, snags a premium spot for sports collectibles. A Prime Spot for Serious...

Continue Reading
Stephen A. Smith Calls for Corporate Support of HBCUs

Updated Category News Views 4

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

Continue Reading

Top 5 Most Recently Viewed Articles

Hyzon Secures Major Order for Hydrogen Fuel Cell Trucks

Updated Category News Views 90

Hyzon Receives Order for Hydrogen Fuel Cell Electric Trucks Hyzon, an innovator in hydrogen fuel cell systems, has announced an exciting new order for two Fuel Cell Electric Trucks (FCETs). This marks a significant step for the company as it continues to provide sustainable solutions for refuse collection through advanced technology. The order comes from a reputable...

Continue Reading
Heron Therapeutics Reports Impressive Financial Gains for 2024

Updated Category News Views 362

Heron Therapeutics Achieves Remarkable Financial Results Heron Therapeutics, Inc. (Nasdaq: HRTX) has announced its outstanding financial performance for 2024, showcasing impressive results that highlight the company's strategic advancements within the biotechnology sector. The company reported a Q4 2024 GAAP net income of $3.6 million, leading to a profitable year-end...

Continue Reading
Imperative Logistics Group Enhances Next-Flight-Out Services

Updated Category News Views 327

Imperative Logistics Group Expands with DTH Expeditors Imperative Logistics Group has recently made a strategic move by acquiring DTH Expeditors, Inc., a prominent provider in high-touch domestic expedited services. This acquisition significantly enhances Imperative's capabilities in the next-flight-out (NFO) logistics sector, which is increasingly vital in today’s...

Continue Reading
Protecting Your Rights as a Five Below, Inc. Shareholder

Updated Category News Views 95

Understanding Your Rights as a Five Below, Inc. Shareholder As a shareholder, it’s crucial to understand your rights in the corporate landscape. Five Below, Inc. (NASDAQ: FIVE) is a well-known company, and being a shareholder means you have a stake in the success and governance of the organization. If you have been investing in its stocks for a significant period,...

Continue Reading
Jefferies Rates Endesa Shares As Hold with Price Target Insights

Updated Category News Views 53

Jefferies Initiates Coverage on Endesa with a Hold Rating Endesa, S.A. (ELE:SM) (OTC: ELEZY) recently came under the spotlight as Jefferies offered new coverage on the stock, assigning it a Hold rating. The analysts set a price target of EUR21.00, a value derived from the company's financial health and the evolving regulatory landscape in Spain. Jefferies emphasized that...

Continue Reading